Amendment To Supply Agreement Sample Contracts

First Amendment to Supply Agreement (May 25th, 2018)

This First Amendment to Supply Agreement (this "Amendment") is made by and between Nanophase Technologies Corporation, a corporation organized and existing under the laws of the State of Delaware, having its principal place of business at 1319 Marquette Drive, Romeoville, IL 60446 ("Supplier"), and Hallstar Ester Solutions Corporation (formerly known as Ester Solutions Company), a Delaware corporation, having its principal place of business at 5851 W 73rd St, Bedford Park, IL, USA 60638 ("Company") (each, a "Party" and together, "Parties").

Third Amendment to Supply Agreement (May 17th, 2018)

This THIRD AMENDMENT TO SUPPLY AGREEMENT (Amendment) is entered into on May 16, 2018, (the Amendment Effective Date) by and between T2 Biosystems, Inc. (Buyer), and SMC Ltd. (Seller).

Third Amendment to Supply Agreement (May 9th, 2018)

This third amendment ("Third Amendment") to the Supply Agreement by and between MannKind Corporation ("MannKind") and Amphastar Pharmaceuticals, Inc. ("Amphastar"), originally dated July 31, 2014 and as previously amended on October 31, 2014 and November 9, 2016 (collectively, the "Agreement"), is hereby made as of the 11th day of April, 2018, by and between MannKind on the one hand, and on the other hand, Amphastar.

First Amendment to Supply Agreement (February 26th, 2018)

This FIRST AMENDMENT TO THE SUPPLY AGREEMENT (the "Amendment") is entered into as of October 26, 2017 (the "Amendment Effective Date") by and between Exelixis, Inc., a Delaware company having an address at 210 East Grand Avenue, South San Francisco, CA 94080, USA ("Exelixis") and Ipsen Pharma SAS, a French corporation having an address at 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France ("Licensee"). Exelixis and Licensee may be referred to herein individually as a "Party" or collectively as the "Parties".

Second Amendment to Supply Agreement (December 27th, 2017)

This SECOND AMENDMENT TO SUPPLY AGREEMENT (Amendment) is entered into on December 22, 2017, (the Amendment Effective Date) by and between T2 Biosystems, Inc. (Buyer), and SMC Ltd. (Seller).

Pgt – First Amendment to Supply Agreement (November 2nd, 2017)

This First Amendment to Supply Agreement (the Amendment) is made and entered into this 1st day of July, 2017, by and between PGT Industries, Inc. (Customer) and ENERGI Fenestration Solutions USA, Inc. (Supplier), and amends that certain Supply Agreement, dated April 28, 2014, by and between Customer and Royal Group, Inc. (the Original Agreement, and together with the Amendment, the Agreement), which Original Agreement subsequently was assigned to Supplier in connection with Suppliers purchase of the window and door division of Royal Group, Inc.;

Oxford Immunotec Global PLC – Second Amendment to Supply Agreement (October 31st, 2017)

This Second Amendment to Supply Agreement (the "Second Amendment") is made and effective as of the final date of signature by the parties below (the "Amendment Effective Date") by and between STEMCELL Technologies Canada Inc. (former corporate name being STEMCELL Technologies Inc.), having a place of business at 570 West 7th Avenue, Suite 400, Vancouver, British Columbia, Canada, V5Z 1B3 ("STEMCELL") and Oxford Immunotec Ltd., having its principal place of business at 94C Innovation Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RZ ("Oxford").

Tpi Composites, Inc – FIRST AMENDMENT to SUPPLY AGREEMENT Between GENERAL ELECTRIC INTERNATIONAL, INC. And TPI MEXICO, LLC (April 20th, 2017)

This FIRST AMENDMENT (the First Amendment) to the SUPPLY AGREEMENT is entered into as of September 28, 2016 (the Effective Date) between GENERAL ELECTRIC INTERNATIONAL, INC., a Delaware corporation, through its GE RENEWABLE ENERGY BUSINESS (formerly known as its GE Power & Water Business), having a principal place of business at 1 River Road, Schenectady, NY 12345 (Buyer or GEREN) and TPI Mexico, LLC, a Delaware limited liability company, having a principal place of business at 8501 N. Scottsdale Road, Suite 100, Scottsdale, AZ 85253 (Seller).

Second Amendment to Supply Agreement (March 16th, 2017)

This second amendment (Second Amendment) to the Supply Agreement by and between MannKind Corporation (MannKind) and Amphastar Pharmaceuticals, Inc. (Amphastar), originally dated July 31, 2014 and as previously amended on October 31, 2014 (collectively, the Agreement), is hereby made as of the 9th day of November, 2016, by and between MannKind on the one hand, and on the other hand, Amphastar.

First Amendment to Supply Agreement (March 16th, 2017)

This first amendment (First Amendment) to the Supply Agreement by and between MannKind Corporation (MannKind) and Amphastar France Pharmaceuticals S.A.S. (AFP), dated July 31, 2014 (the Agreement), is hereby made as of the 31st day of October, 2014, by and between MannKind on the one hand, and on the other hand, AFP and Amphastar Pharmaceuticals, Inc., a Delaware Corporation, having its principal office and place of business at 11570 6th Street, Rancho Cucamonga, CA 91730 (Amphastar).

Amphastar Pharmaceuticals, Inc. – Second Amendment to Supply Agreement (March 15th, 2017)

This second amendment ("Second Amendment") to the Supply Agreement by and between MannKind Corporation ("MannKind") and Amphastar Pharmaceuticals, Inc. ("Amphastar"), originally dated July 31, 2014 and as previously amended on October 31, 2014 (collectively, the "Agreement"), is hereby made as of the 9th day of November, 2016, by and between MannKind on the one hand, and on the other hand, Amphastar.

Pgt – First Amendment to Supply Agreement (March 9th, 2017)

This First Amendment to Supply Agreement (the Amendment) is made and entered into effective January 1, 2017, by and between PGT Industries, Inc. (PGT) and Cardinal LG Company (Supplier), and amends that certain Supply Agreement, dated December 15, 2014, that was entered into between PGT and Supplier (the Agreement).

Tpi Composites, Inc – FIRST AMENDMENT to SUPPLY AGREEMENT Between GENERAL ELECTRIC INTERNATIONAL, INC. And TPI MEXICO, LLC (January 6th, 2017)

This FIRST AMENDMENT (the First Amendment) to the SUPPLY AGREEMENT is entered into as of September 28, 2016 (the Effective Date) between GENERAL ELECTRIC INTERNATIONAL, INC., a Delaware corporation, through its GE RENEWABLE ENERGY BUSINESS (formerly known as its GE Power & Water Business), having a principal place of business at 1 River Road, Schenectady, NY 12345 (Buyer or GEREN) and TPI Mexico, LLC, a Delaware limited liability company, having a principal place of business at 8501 N. Scottsdale Road, Suite 100, Scottsdale, AZ 85253 (Seller).

Natera, Inc. – Third Amendment to Supply Agreement (August 11th, 2016)

This Third Amendment to Supply Agreement (the "Third Amendment") is effective as of the date last signed below (the "Third Amendment Date") between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 ("Illumina") and Natera, Inc., having a place of business at 201 Industrial Road, Suite 410, San Carlos, CA 94070 ("Customer"). Customer and Illumina may be referred to herein as "Party" or "Parties."

Natera, Inc. – Second Amendment to Supply Agreement (August 11th, 2016)

This Second Amendment to Supply Agreement (the "Second Amendment") is effective as of the date last signed below (the "Second Amendment Date") between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 ("Illumina") and Natera, Inc., having a place of business at 201 Industrial Road, Suite 410, San Carlos, CA 94070 ("Customer"). Customer and Illumina may be referred to herein as "Party" or "Parties."

Amendment to Supply Agreement (May 12th, 2016)

THIS AMENDMENT is entered into this 19th day of February, 2016 (the "Effective Date" of the Amendment), by and between ChromaDex, Inc., a corporation duly organized and existing under the laws of California, having its principal place of business at 10005 Muirlands Blvd, Suite G, Irvine, CA 92618 (hereinafter referred to as "ChromaDex") and Elysium Health, Inc, a Delaware corporation, with principal offices located at 594 Broadway Suite 707, New York, NY 10012 (hereinafter referred to as "Elysium Health," and collectively with ChromaDex, the "Parties," and each, a "Party").

Heska Corporation – Amendment to Supply Agreement (November 16th, 2015)

This Amendment to Supply Agreement (the "Amendment") is made and entered into as of August 10, 2015 (the "Amendment Effective Date") by and among Cuattro, LLC, a Colorado limited liability company ("LLC"), and Heska Imaging US, LLC, a Delaware limited liability company formerly known as Cuattro Veterinary U.S.A., LLC ("Vet USA"). This Amendment amends that certain Supply Agreement (the "Agreement") by and between the Parties, dated February 22, 2013. Capitalized terms used but not defined in this Amendment have the meaning ascribed to them in the Agreement.

Synergetics USA, Inc. – AMENDMENT No. 4 TO SUPPLY AGREEMENT (July 22nd, 2015)

THIS AMENDMENT No. 4 TO SUPPLY AGREEMENT ("Amendment No. 4") is entered into by and between Stryker Corporation, a Michigan corporation, acting through its Instruments Division ("Stryker") and Synergetics, Inc., a Missouri corporation ("Supplier").

Amphastar Pharmaceuticals, Inc. – First Amendment to Supply Agreement (November 13th, 2014)

This first amendment ("First Amendment") to the Supply Agreement by and between MannKind Corporation ("MannKind") and Amphastar France Pharmaceuticals S.A.S. ("AFP"), dated July 31, 2014 (the "Agreement"), is hereby made as of the 31st day of October, 2014, by and between MannKind on the one hand, and on the other hand, AFP and Amphastar Pharmaceuticals, Inc., a Delaware Corporation, having its principal office and place of business at 11570 6th Street, Rancho Cucamonga, CA 91730 ("Amphastar").

Fourth Amendment to Supply Agreement (November 10th, 2014)

This Fourth Amendment to Supply Agreement (the Fourth Amendment) is made and entered into as of the 6th day of October 2014 by and between FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDBU), a Delaware corporation with offices at 101 J. Morris Commons Lane, Morrisville, NC 27560, and Dendreon Corporation (Dendreon), a Delaware corporation with offices at 1301 2nd Avenue, Seattle, WA 98101. All capitalized terms used but not defined herein shall have the meanings assigned to them in the Agreement, as hereinafter defined.

Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. SECOND AMENDMENT TO SUPPLY AGREEMENT (November 7th, 2014)

THIS AMENDMENT is entered into this 22nd day of August, 2014, by and between Gnosis Bioresearch srl., a subsidiary fully owned company by GNOSIS SPA organized under the laws of Italy whose head office is located at Via Pomarico, 75010 Pisticci Scalo (MT), Italy, which is registered in the Commercial Register of Matera under No. 01023770777 (Gnosis), and Durata Therapeutics International B.V., a company registered in the Netherlands, with offices at Spaces Zuidas II, Barbara Strozzliaan 101, 1083 HN Amsterdam, the Netherlands (Durata) (collectively the Parties).

Hi-Crush Partners LP – Second Amendment to Supply Agreement (November 4th, 2014)

THIS SECOND AMENDMENT TO SUPPLY AGREEMENT (defined in recitals) (this "Second Amendment") is entered into and effective as of August 8, 2014, by and between Weatherford U.S., L.P., a Louisiana legal entity, on behalf of itself and its affiliates including Weatherford Artificial Lift Systems, L.L.C. (f/k/a Weatherford Artificial Lift Systems, Inc.), a Delaware limited liability company (collectively with its affiliates, "Weatherford"), and Hi-Crush Operating LLC, a Delaware limited liability company, on behalf of itself and its affiliates, including D & I Silica, LLC (collectively with its affiliates "Supplier").

Amendment to Supply Agreement (October 15th, 2014)

This Amendment to Supply Agreement (Amendment) is entered into as of March 20, 2013 (Amendment Effective Date) by and between C.C.C. Del Uruguay S.A. (CCC), an Uruguay corporation with its principal place of business at General Paz 1371, Montevideo, Uruguay, CP 11400, and Nevro Corp. (Nevro), a Delaware corporation with its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025. CCC and Nevro are referred to collectively as the Parties, individually as a Party.

Amendment to Supply Agreement (October 3rd, 2014)

This Amendment to Supply Agreement (Amendment) is entered into as of March 20, 2013 (Amendment Effective Date) by and between C.C.C. Del Uruguay S.A. (CCC), an Uruguay corporation with its principal place of business at General Paz 1371, Montevideo, Uruguay, CP 11400, and Nevro Corp. (Nevro), a Delaware corporation with its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025. CCC and Nevro are referred to collectively as the Parties, individually as a Party.

Amendment to Supply Agreement (September 16th, 2014)

This Amendment to Supply Agreement (Amendment) is entered into as of March 20, 2013 (Amendment Effective Date) by and between C.C.C. Del Uruguay S.A. (CCC), an Uruguay corporation with its principal place of business at General Paz 1371, Montevideo, Uruguay, CP 11400, and Nevro Corp. (Nevro), a Delaware corporation with its principal place of business at 4040 Campbell Avenue, Suite 210, Menlo Park, CA 94025. CCC and Nevro are referred to collectively as the Parties, individually as a Party.

Hi-Crush Partners LP – First Amendment to Supply Agreement (August 5th, 2014)

THIS FIRST AMENDMENT TO SUPPLY AGREEMENT (this "Amendment") is entered into and executed on April 8, 2014 ("Amendment Date"), to be effective as of May 1, 2014 (the "Amendment Effective Date"), by and between FTS International Services, LLC, a limited liability company organized and existing under the laws of the State of Texas and having a principal place of business at 777 Main Street, Suite 3000, Fort Worth, Texas 76102 ("FTSI"), and Hi-Crush Operating LLC, a Delaware limited liability company and having a principal place of business at Three Riverway, Suite 1550, Houston, Texas 77056 ("Supplier").

First Amendment to Supply Agreement (June 19th, 2014)

This First Amendment to Supply Agreement (the Amendment) is entered into effective as of June 12, 2014 (the Amendment Effective Date) by and between Gen-Probe Incorporated, a Delaware corporation, having a principal place of business at 10210 Genetic Center Drive, San Diego, California 92121-4362 (Gen-Probe), and Roka Bioscience, Inc., a Delaware corporation, having a principal place of business at 20 Independence Boulevard, 4th Floor, Warren, New Jersey 07059 (Roka).

Confidential Portions of This Exhibit Marked as [**] Have Been Omitted Pursuant to a Request for Confidential Treatment That Has Been Filed Separately With the Securities and Exchange Commission. Amendment to Supply Agreement (May 20th, 2014)

This Amendment to the Supply Agreement (Amendment), effective as of May 14, 2014 (the Amendment Effective Date), amends that certain Supply Agreement, dated as of November 1, 2010 (the Agreement), by and between Ortho-McNeil-Janssen Pharmaceuticals, Inc., a Pennsylvania corporation ((n/k/a Janssen Pharmaceuticals, Inc.), Janssen) and Watson Laboratories, Inc., a Nevada corporation (Watson, and, together with Janssen, the Parties). All terms used herein and not defined shall have the meaning set forth in the Agreement.

Hi-Crush Partners LP – Amended and Restated First Amendment to Supply Agreement (May 5th, 2014)

THIS AMENDED AND RESTATED FIRST AMENDMENT TO SUPPLY AGREEMENT (defined in recitals) (this "Amendment") is entered into and effective as of May 5, 2014, by and between Weatherford U.S., L.P., a Louisiana legal entity, on behalf of itself and its affiliates including Weatherford Artificial Lift Systems, L.L.C. (f/k/a Weatherford Artificial Lift Systems, Inc.), a Delaware limited liability company (collectively with its affiliates, "Weatherford"), and Hi-Crush Operating LLC, a Delaware limited liability company, on behalf of itself and its affiliates, including D & I Silica, LLC (collectively with its affiliates "Supplier").

Amendment No. 1 to Supply Agreement (January 10th, 2014)

This Amendment No. 1 (this Amendment) to the Supply Agreement dated as of December 11, 2007 (the Supply Agreement) between Synthetic Materials, LLC, a Florida limited liability company (SynMat) and Lafarge North America Inc., a Maryland company (Lafarge) is dated as of this 22nd day of December, 2008.

Amendment to Supply Agreement (November 12th, 2013)

AMENDMENT TO SITAGLIPTIN CATALYST SUPPLY AGREEMENT effective as of Oct 1st 2013 (this "Amendment") by and between Codexis, INC, (the "Vendor"), a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, CA 94063 ("CODEXIS") and MERCK SHARPE and DOHME (the "Company"), having a place of business at One Merck Drive, Whitehouse Station, NJ 08889-0100. ("MERCK")

Confidential Portions of This Exhibit, Denoted by Bracketed Asterisks, Have Been Omitted and Filed Separately With the Securities and Exchange Commission in Reliance on Rule 24b-2 of the Securities Exchange Act of 1934. THIRD AMENDMENT TO SUPPLY AGREEMENT (November 7th, 2013)

This Third Amendment to Supply Agreement (Third Amendment) dated July 22, 2013 (Third Amendment Effective Date) is made by and between Laboratorios PiSA S.A. de C.V., a corporation organized under the laws of Mexico having offices at Calle 7 No. 1308 Zona Industrial, C.P. 44940 Guadalajara, Jal., Mexico (PiSA) and Medisystems Corporation, a Washington corporation, having offices at 350 Merrimack Street, Lawrence, Massachusetts 01843, USA (MDS).

Oxford Immunotec Global PLC – This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. First Amendment to Supply Agreement (October 15th, 2013)

THIS FIRST AMENDMENT TO SUPPLY AGREEMENT (First Amendment) is made and entered into as of the execution by the last party hereto (Amendment Effective Date) by and between EMD Millipore Corporation, (Millipore) and Oxford Immunotec, Ltd. (Oxford).

Oxford Immunotec Global PLC – This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. Amended and Restated Amendment to Supply Agreement (October 15th, 2013)

This amended and restated amendment (the Amendment) is made and effective as of October 26, 2011 by and between STEMCELL Technologies, having a place of business at 570 West 7th Avenue, Suite 400, Vancouver, British Columbia, Canada, V5Z 1B3 and Oxford Immunotec Ltd., having its principal place of business at 94C Milton Park Abingdon, Oxfordshire, United Kingdom, OX14 4RY.

Oxford Immunotec Global PLC – This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [***] and Has Been Filed Separately With the Securities and Exchange Commission. Amended and Restated Amendment to Supply Agreement (September 10th, 2013)

This amended and restated amendment (the Amendment) is made and effective as of October 26, 2011 by and between STEMCELL Technologies, having a place of business at 570 West 7th Avenue, Suite 400, Vancouver, British Columbia, Canada, V5Z 1B3 and Oxford Immunotec Ltd., having its principal place of business at 94C Milton Park Abingdon, Oxfordshire, United Kingdom, OX14 4RY.